Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial.

导出 OA

翻译打印收藏纠错

第一作者： Kequan,Chen

第一单位： Department of Oncology, Guiping People's Hospital, Guiping, Guangxi Zhuang Autonomous Region 537200, P.R. China.

作者： Kequan,Chen ^[1] ; Guoding,Xu ^[2] ; Yong,Liang ^[1] ; Ping,Liang ^[2] ; Weiwei,Gao ^[1] ; Zhou,Li ^[2] ; Weichao,Liang ^[1] ; Zheng,Tao ^[1] ; Jiaxin,Chen ^[3] ; Xiaohua,Hu ^[4] ; Yaocan,Xu ^[1]

作者单位： Department of Oncology, Guiping People's Hospital, Guiping, Guangxi Zhuang Autonomous Region 537200, P.R. China. ^[1] Department of Oncology, The First People's Hospital of Nanning, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530022, P.R. China. ^[2] Department of Oncology and Radiotherapy, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China. ^[3] Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China. ^[4]

关键词 anlotinib cisplatin concurrent chemotherapy locoregionally advanced nasopharyngeal carcinoma

DOI 10.3892/ol.2023.13978

PMID 37600344

发布时间 2023-08-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交